| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer
|
Xu, Tianyue
|
|
|
15 |
5 |
p. 2703-2722
|
artikel
|
| 2 |
A critical role for Phocaeicola vulgatus in negatively impacting metformin response in diabetes
|
Chen, Manyun
|
|
|
15 |
5 |
p. 2511-2528
|
artikel
|
| 3 |
Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses
|
Xu, Tiefeng
|
|
|
15 |
5 |
p. 2498-2510
|
artikel
|
| 4 |
A proximity-induced chimera platform for targeted protein arginine methylation
|
Jian, Yanlin
|
|
|
15 |
5 |
p. 2625-2639
|
artikel
|
| 5 |
Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315]
|
Zhao, Mingxia
|
|
|
15 |
5 |
p. 2810-2812
|
artikel
|
| 6 |
Author correction to “Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury” [Acta Pharm Sin B 12 (2022) 1885–1898]
|
Xue, Tengfei
|
|
|
15 |
5 |
p. 2813-2814
|
artikel
|
| 7 |
CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers
|
Zheng, Liuhai
|
|
|
15 |
5 |
p. 2559-2574
|
artikel
|
| 8 |
Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma
|
Zhang, Hongyan
|
|
|
15 |
5 |
p. 2687-2702
|
artikel
|
| 9 |
Cover Story
|
|
|
|
15 |
5 |
p. xv
|
artikel
|
| 10 |
Design and functional characterization of a tetravalent NK cell-engaging bispecific antibody with enhanced half-life for CD30+ lymphoma
|
Zhao, Caizhi
|
|
|
15 |
5 |
p. 2778-2782
|
artikel
|
| 11 |
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING
|
Lin, Liming
|
|
|
15 |
5 |
p. 2545-2558
|
artikel
|
| 12 |
Editorial of virtual special issue: The development of antiviral drug discovery
|
Du, Shaoqing
|
|
|
15 |
5 |
p. 2801-2804
|
artikel
|
| 13 |
Extrachromosomal DNA as a carrier of extra copies of oncogenes for heterogeneity and malignancy of glioma
|
Wang, Lin-jian
|
|
|
15 |
5 |
p. 2791-2794
|
artikel
|
| 14 |
First ATG101-recruiting small molecule degrader for selective CDK9 degradation via autophagy–lysosome pathway
|
Zhong, Ye
|
|
|
15 |
5 |
p. 2612-2624
|
artikel
|
| 15 |
Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure
|
Marie, Solène
|
|
|
15 |
5 |
p. 2736-2745
|
artikel
|
| 16 |
Inhaled non-viral delivery systems for RNA therapeutics
|
Huang, Cheng
|
|
|
15 |
5 |
p. 2402-2430
|
artikel
|
| 17 |
Inhibition of CCT5-mediated asparagine biosynthesis and anti-PD-L1 produce synergistic antitumor effects in colorectal cancer
|
Zhang, Yujie
|
|
|
15 |
5 |
p. 2480-2497
|
artikel
|
| 18 |
Innovative discovery and mechanistic validation of HyT-PD ligands for selective CDK9-targeted protein degradation
|
Zhai, Yizhan
|
|
|
15 |
5 |
p. 2808-2809
|
artikel
|
| 19 |
Marine-derived new peptaibols with antibacterial activities by targeting bacterial membrane phospholipids
|
Chen, Shang
|
|
|
15 |
5 |
p. 2764-2777
|
artikel
|
| 20 |
Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway
|
Zhang, Yuanyuan
|
|
|
15 |
5 |
p. 2655-2672
|
artikel
|
| 21 |
Modified probiotics and the related combinatorial therapeutics
|
Zhao, Luo
|
|
|
15 |
5 |
p. 2431-2453
|
artikel
|
| 22 |
Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders
|
Jiang, Chenyao
|
|
|
15 |
5 |
p. 2351-2362
|
artikel
|
| 23 |
NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke
|
Yang, Li
|
|
|
15 |
5 |
p. 2575-2592
|
artikel
|
| 24 |
Phenotypic plasticity and secretory heterogeneity in subpopulations derived from single cancer cell
|
Lin, Zhun
|
|
|
15 |
5 |
p. 2723-2735
|
artikel
|
| 25 |
Precise nanoscale fabrication technologies, the “last mile” of medicinal development
|
Bi, Ye
|
|
|
15 |
5 |
p. 2372-2401
|
artikel
|
| 26 |
Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation
|
Lin, Ling
|
|
|
15 |
5 |
p. 2746-2763
|
artikel
|
| 27 |
RNA splicing: Novel star in pulmonary diseases with a treatment perspective
|
Niu, Zhihui
|
|
|
15 |
5 |
p. 2301-2322
|
artikel
|
| 28 |
Skin as an autonomous immune organ: Antibody production and host protection
|
Deng, Wende
|
|
|
15 |
5 |
p. 2795-2797
|
artikel
|
| 29 |
SMAD4 depletion enhances NHEJ by regulating BRCA1 expression through ARIH1 in pancreatic cancer
|
Song, Yiran
|
|
|
15 |
5 |
p. 2787-2790
|
artikel
|
| 30 |
Structural insights into the binding modes of lanreotide and pasireotide with somatostatin receptor 1
|
Zeng, Zicheng
|
|
|
15 |
5 |
p. 2468-2479
|
artikel
|
| 31 |
Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
|
Wang, Zheng
|
|
|
15 |
5 |
p. 2673-2686
|
artikel
|
| 32 |
Table of Contents
|
|
|
|
15 |
5 |
p. iii-xiv
|
artikel
|
| 33 |
Targeting copper homeostasis: Akkermansia-derived OMVs co-deliver Atox1 siRNA and elesclomol for cancer therapy
|
Hamza, Muhammad
|
|
|
15 |
5 |
p. 2640-2654
|
artikel
|
| 34 |
Targeting stiff stroma by neutralizing LOX-mediated matrix crosslinking in pancreatic cancer
|
Zhang, Shan
|
|
|
15 |
5 |
p. 2783-2786
|
artikel
|
| 35 |
Targeting the JAK2–STAT3–UCHL3–ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer
|
Xin, Haisong
|
|
|
15 |
5 |
p. 2529-2544
|
artikel
|
| 36 |
The neuroscience of cancer: Focus on neuropeptidergic systems
|
Dong, Zikai
|
|
|
15 |
5 |
p. 2323-2350
|
artikel
|
| 37 |
TRIM21-based degradation strategy for multimeric proteins
|
Wang, Wei
|
|
|
15 |
5 |
p. 2798-2800
|
artikel
|
| 38 |
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
|
Ou, Yang
|
|
|
15 |
5 |
p. 2593-2611
|
artikel
|
| 39 |
VenusMutHub—A benchmark for protein mutation effect prediction
|
Yu, Junlin
|
|
|
15 |
5 |
p. 2805-2807
|
artikel
|
| 40 |
VenusMutHub: A systematic evaluation of protein mutation effect predictors on small-scale experimental data
|
Zhang, Liang
|
|
|
15 |
5 |
p. 2454-2467
|
artikel
|
| 41 |
“Weibing” in traditional Chinese medicine—biological basis and mathematical representation of disease-susceptible state
|
Sun, Wanyang
|
|
|
15 |
5 |
p. 2363-2371
|
artikel
|
Tijdschrift beschrijving